Active migration and passive transport of malaria parasites

Trends in Parasitology

Volumn 31, Issue 8, 2015, Pages 357-362

  Douglas, Ross G ^a   Amino, Rogerio ^b   Sinnis, Photini ^c   Frischknecht, Freddy ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b INSTITUT PASTEUR   (France)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Active migration; Drug targeting; Parasite dissemination; Passive transport; Vaccine design

Indexed keywords

MALARIA VACCINE; ANTIMALARIAL AGENT;

COMPLEMENT DEPENDENT CYTOTOXICITY; ERYTHROCYTE; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; LIVER CELL; MALARIA; MEROZOITE; MOLECULAR WEIGHT; MOSQUITO; NONHUMAN; PARASITE MIGRATION; PARASITE TRANSMISSION; PASSIVE TRANSPORT; PHASE 3 CLINICAL TRIAL (TOPIC); PLASMODIUM; PLASMODIUM (LIFE CYCLE STAGE); REVIEW; SPOROZOITE; ANIMAL; LIFE CYCLE STAGE; PARASITOLOGY; PHYSIOLOGY; SKIN;

MAMMALIA;

ANIMALS; ANTIMALARIALS; CULICIDAE; HOST-PARASITE INTERACTIONS; HUMANS; LIFE CYCLE STAGES; MALARIA; PLASMODIUM; SKIN; SPOROZOITES;

EID: 84938740767     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2015.04.010     Document Type: Review

References (87)

1. Flannery E.L., et al. Antimalarial drug discovery - approaches and progress towards new medicines. Nat. Rev. Microbiol. 2013, 11:849-862.
2. Sinnis P., Zavala F. The skin: where malaria infection and the host immune response begin. Semin. Immunopathol. 2012, 34:787-792.
3. Menard R., et al. Looking under the skin: the first steps in malarial infection and immunity. Nat. Rev. Microbiol. 2013, 11:701-712.
4. Tilley L., et al. The Plasmodium falciparum-infected red blood cell. Int. J. Biochem. Cell Biol. 2011, 43:839-842.
5. Collins W.E., Jeffery G.M. Plasmodium malariae: parasite and disease. Clin. Microbiol. Rev. 2007, 20:579-592.
6. Haldar K., et al. Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu. Rev. Pathol. 2007, 2:217-249.
7. Hall J., Ross E. Malaria: The Battle Against a Microscopic Killer 2012, EVIMalaR.
8. Bousema T., et al. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat. Rev. Microbiol. 2014, 12:833-840.
9. Kappe S.H., et al. Plasmodium sporozoite molecular cell biology. Annu. Rev. Cell Dev. Biol. 2004, 20:29-59.
10. Amino R., et al. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat. Med. 2006, 12:220-224.
11. Sidjanski S., Vanderberg J.P. Delayed migration of Plasmodium sporozoites from the mosquito bite site to the blood. Am. J. Trop. Med. Hyg. 1997, 57:426-429.
12. Matsuoka H., et al. A rodent malaria, Plasmodium berghei, is experimentally transmitted to mice by merely probing of infective mosquito, Anopheles stephensi. Parasitol. Int. 2002, 51:17-23.
13. Medica D.L., Sinnis P. Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes. Infect. Immun. 2005, 73:4363-4369.
14. Amino R., et al. In vivo imaging of malaria parasites - recent advances and future directions. Curr. Opin. Microbiol. 2005, 8:407-414.
15. Yamauchi L.M., et al. Plasmodium sporozoites trickle out of the injection site. Cell. Microbiol. 2007, 9:1215-1222.
16. Ejigiri I., et al. Shedding of TRAP by a rhomboid protease from the malaria sporozoite surface is essential for gliding motility and sporozoite infectivity. PLoS Pathog. 2012, 8:e1002725.
17. Volkmann K., et al. The alveolin IMC1h is required for normal ookinete and sporozoite motility behaviour and host colonisation in Plasmodium berghei. PLoS ONE 2012, 7:e41409.
18. Hellmann J.K., et al. Environmental constraints guide migration of malaria parasites during transmission. PLoS Pathog. 2011, 7:e1002080.
19. Montagna G.N., et al. Critical role for heat shock protein 20 (HSP20) in migration of malarial sporozoites. J. Biol. Chem. 2012, 287:2410-2422.
20. Amino R., et al. Host cell traversal is important for progression of the malaria parasite through the dermis to the liver. Cell Host Microbe 2008, 3:88-96.
21. Moreira C.K., et al. The Plasmodium TRAP/MIC2 family member, TRAP-like protein (TLP), is involved in tissue traversal by sporozoites. Cell Microbiol. 2008, 10:1505-1516.
22. Bhanot P., et al. A surface phospholipase is involved in the migration of Plasmodium sporozoites through cells. J. Biol. Chem. 2005, 280:6752-6760.
23. Sack B.K., et al. Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infect. Immun. 2014, 82:808-817.
24. Vanderberg J.P., Frevert U. Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes. Int. J. Parasitol. 2004, 34:991-996.
25. Kebaier C., et al. Kinetics of mosquito-injected Plasmodium sporozoites in mice: fewer sporozoites are injected into sporozoite-immunized mice. PLoS Pathog. 2009, 5:e1000399.
26. Sinnis P., et al. Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes. J. Exp. Med. 1996, 184:945-954.
27. Cerami C., et al. Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes. J. Exp. Med. 1994, 179:695-701.
28. Shin S.C., et al. Direct infection of hepatocytes by sporozoites of Plasmodium berghei. J. Protozool. 1982, 29:448-454.
29. Vanderberg J., et al. Assessment of antibody protection against malaria sporozoites must be done by mosquito injection of sporozoites. Am. J. Pathol. 2007, 171:1405-1406.
30. Frevert U., et al. Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol. 2005, 3:e192.
31. Tavares J., et al. Role of host cell traversal by the malaria sporozoite during liver infection. J. Exp. Med. 2013, 210:905-915.
32. Sultan A.A., et al. TRAP is necessary for gliding motility and infectivity of Plasmodium sporozoites. Cell 1997, 90:511-522.
33. Sato Y., et al. Plasmodium berghei sporozoites acquire virulence and immunogenicity during mosquito hemocoel transit. Infect. Immun. 2014, 82:1164-1172.
34. Coppi A., et al. Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells. Cell Host Microbe 2007, 2:316-327.
35. Pradel G., et al. Proteoglycans mediate malaria sporozoite targeting to the liver. Mol. Microbiol. 2002, 45:637-651.
36. + T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 2007, 13:1035-1041.
37. Guilbride D.L., et al. Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model. PLoS ONE 2010, 5:e10685.
38. Obeid M., et al. Skin-draining lymph node priming is sufficient to induce sterile immunity against pre-erythrocytic malaria. EMBO Mol. Med. 2013, 5:250-263.
39. Campo J.J., et al. Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS, S/AS02 in Mozambique. Vaccine 2014, 32:2209-2216.
40. White M.T., et al. A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine. BMC Med. 2014, 12:117.
41. Arama C., Troye-Blomberg M. The path of malaria vaccine development: challenges and perspectives. J. Intern. Med. 2014, 275:456-466.
42. Sreenivasamurthy S.K., et al. A compendium of molecules involved in vector-pathogen interactions pertaining to malaria. Malar. J. 2013, 12:216.
43. Baton L.A., et al. Genome-wide transcriptomic profiling of Anopheles gambiae hemocytes reveals pathogen-specific signatures upon bacterial challenge and Plasmodium berghei infection. BMC Genomics 2009, 10:257.
44. Gunn A., Pitt S.J. Parasitology: An Integrated Approach 2012, John Wiley & Sons.
45. Kariu T., et al. MAEBL is essential for malarial sporozoite infection of the mosquito salivary gland. J. Exp. Med. 2002, 195:1317-1323.
46. Golenda C.F., et al. The distribution of circumsporozoite protein (CS) in Anopheles stephensi mosquitoes infected with Plasmodium falciparum malaria. J. Histochem. Cytochem. 1990, 38:475-481.
47. Frischknecht F., et al. Using green fluorescent malaria parasites to screen for permissive vector mosquitoes. Malar. J. 2006, 5:23.
48. Akaki M., Dvorak J.A. A chemotactic response facilitates mosquito salivary gland infection by malaria sporozoites. J. Exp. Biol. 2005, 208:3211-3218.
49. Sterling C.R., et al. The passage of Plasmodium berghei sporozoites through the salivary glands of Anopheles stephensi: an electron microscope study. J. Parasitol. 1973, 59:593-605.
50. Pimenta P.F., et al. The journey of malaria sporozoites in the mosquito salivary gland. J. Eukaryot. Microbiol. 1994, 41:608-624.
51. Frischknecht F., et al. Imaging movement of malaria parasites during transmission by Anopheles mosquitoes. Cell. Microbiol. 2004, 6:687-694.
52. Meis J.F., et al. Fine structure of exoerythrocytic merozoite formation of Plasmodium berghei in rat liver. J. Protozool. 1985, 32:694-699.
53. Sturm A., Heussler V. Live and let die: manipulation of host hepatocytes by exoerythrocytic Plasmodium parasites. Med. Microbiol. Immunol. 2007, 196:127-133.
54. Graewe S., et al. Chronicle of a death foretold: Plasmodium liver stage parasites decide on the fate of the host cell. FEMS Microbiol. Rev. 2012, 36:111-130.
55. Sturm A., et al. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 2006, 313:1287-1290.
56. Baer K., et al. Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog. 2007, 3:e171.
57. Baum J., et al. Host-cell invasion by malaria parasites: insights from Plasmodium and Toxoplasma. Trends Parasitol. 2008, 24:557-563.
58. Abkarian M., et al. A novel mechanism for egress of malarial parasites from red blood cells. Blood 2011, 117:4118-4124.
59. Rodriguez L.E., et al. Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design. Chem. Rev. 2008, 108:3656-3705.
60. Chandramohanadas R., et al. Small molecule targeting malaria merozoite surface protein-1 (MSP-1) prevents host invasion of divergent plasmodial species. J. Infect. Dis. 2014, 210:1616-1626.
61. O'Donnell R.A., et al. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. J. Exp. Med. 2001, 193:1403-1412.
62. Barry A.E., Arnott A. Strategies for designing and monitoring malaria vaccines targeting diverse antigens. Front. Immunol. 2014, 5:359.
63. Wright G.J., Rayner J.C. Plasmodium falciparum erythrocyte invasion: combining function with immune evasion. PLoS Pathog. 2014, 10:e1003943.
64. Kadekoppala M., Holder A.A. Merozoite surface proteins of the malaria parasite: the MSP1 complex and the MSP7 family. Int. J. Parasitol. 2010, 40:1155-1161.
65. Giovannini D., et al. Independent roles of apical membrane antigen 1 and rhoptry neck proteins during host cell invasion by apicomplexa. Cell Host Microbe 2011, 10:591-602.
66. Bargieri D.Y., et al. Apical membrane antigen 1 mediates apicomplexan parasite attachment but is dispensable for host cell invasion. Nat. Commun. 2013, 4:2552.
67. Kuehn A., Pradel G. The coming-out of malaria gametocytes. J. Biomed. Biotechnol. 2010, 2010:976827.
68. Sinden R.E., Croll N.A. Cytology and kinetics of microgametogenesis and fertilization in Plasmodium yoelii nigeriensis. Parasitology 1975, 70:53-65.
69. Gwadz R.W. Successful immunization against the sexual stages of Plasmodium gallinaceum. Science 1976, 193:1150-1151.
70. Carter R., et al. Plasmodium gallinaceum: transmission-blocking immunity in chickens. II. The effect of antigamete antibodies in vitro and in vivo and their elaboration during infection. Exp. Parasitol. 1979, 47:194-208.
71. Healer J., et al. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230. Parasitology 1999, 119:425-433.
72. Hirai M., Mori T. Fertilization is a novel attacking site for the transmission blocking of malaria parasites. Acta Trop. 2010, 114:157-161.
73. Ojo K.K., et al. Transmission of malaria to mosquitoes blocked by bumped kinase inhibitors. J. Clin. Invest. 2012, 122:2301-2305.
74. Angrisano F., et al. Malaria parasite colonisation of the mosquito midgut - placing the Plasmodium ookinete centre stage. Int. J. Parasitol. 2012, 42:519-527.
75. Barr P.J., et al. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J. Exp. Med. 1991, 174:1203-1208.
76. Shahabuddin M., et al. Transmission-blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:4266-4270.
77. Birkett A.J., et al. Malaria vaccine R&D in the Decade of Vaccines: breakthroughs, challenges and opportunities. Vaccine 2013, 31(Suppl. 2):B233-B243.
78. Yilmaz B., et al. Gut microbiota elicits a protective immune response against malaria transmission. Cell 2014, 159:1277-1289.
79. Baum J., et al. Regulation of apicomplexan actin-based motility. Nat. Rev. Microbiol. 2006, 4:621-628.
80. Hellmann J.K., et al. Synergistic and additive effects of epigallocatechin gallate and digitonin on Plasmodium sporozoite survival and motility. PLoS ONE 2010, 5:e8682.
81. Lentz C.S., et al. In vitro activity of wALADin benzimidazoles against different life cycle stages of Plasmodium parasites. Antimicrob. Agents Chemother. 2015, 59:654-658.
82. Liehl P., et al. Phosphothioate oligodeoxynucleotides inhibit Plasmodium sporozoite gliding motility. Cell. Microbiol. 2010, 12:506-515.
83. Miller L.H., et al. Interaction between cytochalasin B-treated malarial parasites and erythrocytes. Attachment and junction formation. J. Exp. Med. 1979, 149:172-184.
84. Siden-Kiamos I., et al. Involvement of actin and myosins in Plasmodium berghei ookinete motility. Mol. Biochem. Parasitol. 2006, 150:308-317.
85. Munter S., et al. Plasmodium sporozoite motility is modulated by the turnover of discrete adhesion sites. Cell Host Microbe 2009, 6:551-562.
86. Mizuno Y., et al. Effect of jasplakinolide on the growth, invasion, and actin cytoskeleton of Plasmodium falciparum. Parasitol. Res. 2002, 88:844-848.
87. Spangenberg T., et al. The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS ONE 2013, 8:e62906.